Loading organizations...
Key people at Adaptiv Capital.
Adaptiv Capital is a privately held corporate entity whose specific business operations, primary industry focus, and official headquarters location remain undisclosed in standard verified public market databases. The firm currently operates without publicly sharing its core business model, target market sectors, or the exact nature of its commercial products and services. Key financial metrics and indicators of operational scale, including total funding raised, assets under management, corporate valuation figures, and current employee headcount, are not available for public review. Furthermore, the organization has not disclosed any recognizable corporate names associated with its ongoing operations, such as institutional lead investors, active portfolio companies, strategic partners, or enterprise customers. Specific details regarding the exact founding year and the identities of the original founders of Adaptiv Capital are currently unverified and absent from major public corporate registries.
Key people at Adaptiv Capital.
Adaptive Capital Partners is a Singapore-based venture capital firm founded in 2022, focusing on early-stage investments in technology, health tech, and medtech companies across Southeast Asia.[3][4] Its mission centers on backing innovative startups in these sectors, with a track record of three investments, including a $3.5M Series A in Biorithm in December 2023.[3] The firm operates within the broader investment ecosystem, targeting high-growth opportunities in a region poised for tech expansion, though details on its full investment philosophy or startup ecosystem impact remain limited in available data.[4]
Note: Multiple entities share similar names, such as Adaptivv (a Swiss risk management firm for pension funds since 2016)[1], Adaptive Capital (a crypto hedge fund)[2], and Adaptive Capital Partners' financial advisory arm for middle-market companies[5]. This overview prioritizes the VC firm matching the query's "Adaptiv Capital" phrasing and investment context.[3][4]
Adaptive Capital Partners was established in 2022 in Singapore as an early-stage VC firm.[3] Limited public details exist on key partners or founders, but the firm quickly ramped up activity, completing its first noted investments by late 2022.[3] Its evolution has centered on Southeast Asia's tech and health sectors, aligning with regional growth in digital health and innovation post-pandemic.[4]
Adaptive Capital Partners rides the wave of Southeast Asia's tech boom, where health tech and medtech address aging populations, digital transformation, and post-COVID healthcare demands.[4] Timing is favorable amid rising VC interest in SEA (e.g., 2022-2023 funding surges), with market forces like government incentives in Singapore and Indonesia boosting startups.[3] The firm influences the ecosystem by funding early-stage innovators, potentially accelerating medtech adoption in a region with 670M+ people and expanding digital infrastructure.
Adaptive Capital Partners is poised for expansion as SEA's tech ecosystem matures, with trends like AI-driven health tech and regulatory easing shaping its pipeline.[4] Expect more Series A deals in medtech amid 2025's projected funding rebound; its influence could grow by building a concentrated portfolio of regional unicorns. This early-stage focus positions it to capture outsized returns in a high-potential market, echoing its nimble start since 2022.[3]
